NDC17478-0040-01 by Akorn Inc - Receive a Competitive Quote
| Part Number: NDC17478-0040-01 | Alternate P/N: NDC17478004001 | Manufacturer: Akorn Inc | NSN : 6505-01-650-2681 | Item Name : Lorazepam Injection | CAGE Code: 55751 | ||
We’re excited to announce that NDC17478-0040-01 NSN part is now available and ready for immediate shipping. Part number NDC17478-0040-01 is a Lorazepam Injection manufactured by Akorn Inc with NSN 6505016502681. Are you interested in a quick and competitive quote for this part?
Just NSN Parts, owned and operated by ASAP Semiconductor, is a leading distributor of NSN (National Stock Number) parts, new and obsolete. Because of our dedication to quality, we’re the only independent distributor in the United States with a strict No China Sourcing Pledge. We’re also an AS9120B, ISO 9001:2015 certified, and FAA AC 0056B accredited member of the Aviation Suppliers Association (ASA). Our vast and comprehensive inventory of over 2 billion parts coupled with our shipping facilities in Washington, Oregon, California, New Maxico, Nevada, Arizona, Illinois, Minnesota, Pennsylvania, and New York, allow us to offer you some of the fastest delivery times in the industry.
If you’d like to learn more about NSN part number NDC17478-0040-01 Lorazepam Injection, feel free to call us at our toll-free number, +1-714-705-4780, or email us at sales@justnsnparts.com. And, if you’d like to stay informed on new inventory or any promotions, feel free to download the ASAP Semiconductor App from Google Play or the App Store.
NSN Information for Part Number NDC17478-0040-01 with NSN 6505-01-650-2681, 6505016502681
| NSN | FSC | NIIN | CLS | Hazmat | DEMIL | Cancelled NSN |
|---|---|---|---|---|---|---|
| 6505-01-650-2681 Item PartTypeName: LORAZEPAM INJECTION | 6505 | 016502681 | M | P | ||
| CIIC | HCC | ESD | PMIC | Criticality | ENAC | |
| Q | A | 0 | ||||
| Part Number | ISC | RNVC | RNCC | HCC | MSDS | SADC |
| 1389508 | 5 | 1 | 5 |
Characteristics Data of NSN 6505-01-650-2681, 6505016502681
| MRC | Criteria | Characteristic |
|---|---|---|
| AJCN | PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| AKJQ | PHARMACEUTICAL VEHICLE TYPE | AQUEOUS |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 2.0 MILLILITERS |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 2.0 MILLIGRAMS LORAZEPAM PER MILLIGRAM |
| CQCT | PRIMARY CONTAINER TYPE | VIAL |
| CRYC | CONTROLLED SUBSTANCE CLASSIFICATION | SCHEDULE IV |
| CSGS | ADMINISTRATION | INTRAVENOUS AND INTRAMUSCULAR |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ATIVAN INJECTION 2 MG/ML VIAL 1 ML, 10 VIALS PER PACKAGE |
| FEAT | SPECIAL FEATURES | LORAZEPAM 2 MG-ML VL 10X1 ML; SCHEDULE IV DEA CONTROLLED SUBSTANCE; INTENDED FOR THE INTRAMUSCULAR OR INTRAVENOUS ROUTES OF ADMINISTRATION; EACH ML OF STERILE INJECTION CONTAINS EITHER 2 MILLIGRAMS OF LORAZEPAM; CONCENTRATION/STRENGTH: 2 MG |
